Breaking

Iran tight-lipped on cause of deadly port explosion amid reports of possible presence of chemicals used to fuel missiles
Russian military turns to motorbikes to evade Ukrainian drones on frontlines
Israeli airstrike rocks southern Beirut after military issues evacuation warning
Canadian Filipinos mourn after car ramming attack on their community. Here’s what we know
Trump’s plan to give Ukrainian land to Russia ‘a capitulation,’ Germany warns, as Putin thanks North Korea for troops
China rejects Trump’s claim that Xi has called him by phone
China and Philippines unfurl competing flags on disputed South China Sea sandbars, reviving tensions
Yemen’s Houthis claim dozens killed in alleged US airstrike on prison holding African migrants

Business
World News
Investing
Science
Search for:

Investing

First patient dosed in Phase IIb imaging for Brain Mets

Share on Facebook Share on Twitter Pinterest LinkedIn Tumblr Email

Share

Share on Facebook Share on Twitter Pinterest Email

Radiopharm Theranostics (RAD:AU) has announced First patient dosed in Phase IIb imaging for Brain Mets

Download the PDF here.

This post appeared first on investingnews.com

0

admin

Website

Related Posts

Silver Crown Royalties Announces Closing of Final Tranche of its Non-Brokered Private Placement

Stagflation Looms: Why Economists Are Warning of a Rare and Painful Economic Storm

Binding Commitments Received for A$1.0 Million under Convertible Note Placement

Get free access to all of the retirement secrets and income strategies from our experts! or Join The Exclusive Subscription Today And Get the Premium Articles Acess for Free

Your name

Your email

By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.
Categories
- Business (104)
- Investing (427)
- Science (10)
- World News (518)

Disclaimer: investmentintelligencesphere.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.
Latest Posts

Copyright © 2025 investmentintelligencesphere.com | All Rights Reserved

Top

Business
World News
Investing
Science

Type above and press Enter to search. Press Esc to cancel.